1)  Yashiro Y, Arimoto T, Hashimoto N, Tamura H, Iwayama T, Ishigaki D, Kumagai Y, Nishiyama S, Takahashi H, Shishido T, Miyamoto T, Watanabe T, Kubota I: Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients. Circ J. 2015; 79: 61-69

2)  Daidoji H, Takahashi H, Otaki Y, Tamura H, Arimoto T, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I: A combination of plaque components analyzed by integrated backscatter intravascular ultrasound and serum pregnancy-associated plasma protein a levels predict the no-reflow phenomenon during percutaneous coronary intervention. Catheter Cardiovasc Interv. 2015; 85(1): 43-50

3)  Hirayama A, Konta T, Hozawa A, Kawasaki R, Watanabe T, Shibata Y, Kayama T, Fukao A, Kubota I: Slight increase in urinary albumin excretion within the normal range predicts incident hypertension in a community-based Japanese population: the Takahata study. Hypertens Res. 2015; 38(1): 56-60

4)  Narumi T, Shishido T, Otaki Y, Kadowaki S, Honda Y, Funayama A, Honda S, Hasegawa H, Kinoshita D, Yokoyama M, Nishiyama S, Takahashi H, Arimoto T, Miyamoto T, Watanabe T, Tanaka A, Woo CH, Abe J, Takeishi Y, Kubota I: High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis. J Mol Cell Cardiol. 2015; 82: 1-12

5)  Narumi T, Watanabe T, Kadowaki S, Takahashi T, Yokoyama M, Kinoshita D, Honda Y, Funayama A, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyamoto T, Kubota I: Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Intern Med. 2015; 26(2): 118-122

6)  Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators: Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure. Int Heart J. 2015; 56(2): 213-218

7)  Niizeki T, Ishino M, Kitahara T, Yamauchi S, Ikeno E, Kubota I: Endovascular therapy for fibromuscular dysplasia of the bilateral external iliac arteries visualized with optical coherence tomography. Am J Case Rep. 2015; 16: 187-190

8)  Daimon M, Konta T, Oizumi T, Kameda W, Susa S, Terui K, Nigawara T, Kageyama K, Ueno Y, Kubota I, Yamashita H, Kayama T, Kato T: Lower aldosterone-renin ratio is a risk factor for total and cancer death in Japanese individuals: the Takahata study. Clin Endocrinol (Oxf). 2015; 82(4): 489-496

9)  Ishino M, Shishido T, Suzuki S, Katoh S, Sasaki T, Funayama A, Netsu S, Hasegawa H, Honda S, Takahashi H, Arimoto T, Miyashita T, Miyamoto T, Watanabe T, Takeishi Y, Kubota I: Deficiency of long pentraxin PTX3 promoted neointimal hyperplasia after vascular injury. J Atheroscler Thromb. 2015; 22(4): 372-378

10)Narimatsu H, Nakata Y, Nakamura S, Sato H, Sho R, Otani K, Kawasaki R, Kubota I, Ueno Y, Kato T, Yamashita H, Fukao A, Kayama T: Applying data envelopment analysis to preventive medicine: a novel method for constructing a personalised risk model of obesity. PloS One. 2015; 10(5): e0126443

11)Inoue S, Shibata Y, Kishi H, Hasegawa H, Nitobe J, Iwayama T, Yashiro Y, Nemoto T, Sato K, Nakano H, Sato M, Nunomiya K, Aida Y, Yamauchi K, Igarashi A, Abe S, Kubota I: Low arterial blood oxygenation is associated with calcification of the coronary arteries in patients with chronic obstructive pulmonary disease. Respir Investig. 2015; 53(3): 111-116

12)Otaki Y, Takahashi H, Watanabe T, Yamaura G, Funayama A, Arimoto T, Shishido T, Miyamoto T, Kubota I: Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease.BBA Clinical. 2015; 18(4): 35-41

13)Funayama A, Watanabe T, Otaki Y, Nishiyama S, Arimoto T, Takahashi H, Shishido T, Miyamoto T, Kubota I: Utility of the Japan arteriosclerosis longitudinal study score for identifying a high risk for vasospastic angina. Intern Med. 2015; 54(8): 881-885

14)Nakamura Y, Suzuki S, Shimizu T, Miyata M, Shishido T, Ikeda K, Saitoh S, Kubota I, Takeishi Y: High mobility group box 1 promotes angiogenesis from bone marrow-derived endothelial progenitor cells after myocardial infarction. J Atheroscler Thromb. 2015; 22(6): 570-581

15)Chishaki A, Kumagai N, Takahashi N, Saikawa T, Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Sakurai M, Kawamura Y, Kubota I, Matsumoto K, Kaneko Y, Ogawa S, Aizawa Y, Chinushi M, Kodama I, Watanabe E, Koretsune Y, Okuyama Y, Shimizu A, Igawa O, Bando S, Fukatani M; J-RHYTHM Registry Investigators. Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry. Thromb Res. 2015; 136(2): 267-273

16)Kadowaki S, Kaneko K, Omi K, Ito M, Kubota I: Left ventricular thrombus accompanied by intra-ventricular obstruction in a patient with acute cerebral embolism and hypereosinophilic syndrome. J Echocardiogr. 2015; 13(3): 118-120

17)Liombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodriguez-Yanez M, Fonseca AC, Watanabe T, Purroy F, Zhixin Wu, Etgen T, Hosomi N, Kerman SRJ, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, Garcia-Berrocoso T, Montaner J: B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke. 2015; 46: 1187-1195

18)Terawaki H, Nakayama M, Asahi K, Kakamu T, Hayakawa T, Iseki K, Kimura K, Moriyama T, Yamagata K, Narita I, Fujimoto S, Tsuruya K, Konta T, Kondo M, Kurahashi I, Ohashi Y, Fukushima T, Watanabe T: Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation. Clin Exp Nephrol. 2015; 19(3): 387-394

19)Uchida D, Kawarazaki H, Shibagaki Y, Yasuda T, Tominaga N, Watanabe T, Asahi K, Iseki K, Iseki C, Tsuruya K, Yamagata K, Moriyama T, Narita I, Fujimoto S, Konta T, Kondo M, Kasahara M, Kimura K: Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population. Clin Exp Nephrol. 2015; 19(3): 474-480

20)Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Asahi K, Kimura K, Kondo M, Kurahashi I, Ohashi Y, Watanabe T: Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol. 2015; 41(2): 138-146

21)Yano Y, Fujimoto S, Kramer H, Sato Y, Konta T, Iseki K, Iseki C, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kimura K, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese General Population. Hypertension. 2015; 66(1): 30-36

22)Ito H, Hozawa A, Yamashita H, Kubota I, Nemoto K, Yoshioka T, Kayama T, Murakami M: Employment status among non-retired cancer survivors in Japan. Eur J Cancer Care (Engl). 2015; 24(5): 718-723

23)Daimon M, Oizumi T, Kameda W, Matsui J, Murakami H, Ueno Y, Kubota I, Yamashita H, Kayama T, Kato T: Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study. J Atheroscler Thromb. 2015; 22(10): 1030-1039

24)Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Kimura K, Narita I, Kondo M, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015; 28(9): 1150-1156

25)Narumi T, Watanabe T, Kubota I: Letter to the Editor: Simple measurement popularizes sarcopenia evaluation in patients with heart failure. Eur J Intern Med. 2015; 26(8): e35

26)Otaki Y, Takahashi H, Watanabe T, Yamaura G, Funayama A, Arimoto T, Shishido T, Miyamoto T, Kubota I: Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients. Circ J. 2015; 79(11): 2480-2486

27)Ishigaki D, Arimoto T, Iwayama T, Hashimoto N, Kutsuzawa D, Kumagai Y, Nishiyama S, Takahashi H, Shishido T, Miyamoto T, Watanabe T, Kubota I: Prevention of immediate recurrence of atrial fibrillation with low-dose landiolol after radiofrequency catheter ablation. J Arrhythm. 2015; 31(5): 279-285

28)Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Kimura K, Narita I, Kondo M, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations. Clin Exp Nephrol. 2015; 19(5): 790-796

29)Shimizu T, Suzuki S, Sato A, Nakamura Y, Ikeda K, Saitoh S, Misaka S, Shishido T, Kubota I, Takeishi Y: Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury. J Mol Cell Cardiol. 2015; 89(Pt B): 306-313

30)Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, Fujimoto S,Konta T, Moriyama T, Yamagata K, Narita I, Kimura K, Kondo M, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015; 66(6): 972-983

31)山口宏,奥本和夫,大本英次郎,今田恒夫: 第10回東北支部専門医部会教育セミナーまとめ 症例:縦隔リンパ節腫脹を認めた難治性腹水の1. 日本内科学会雑誌. 2015; 104(6): 1213-1222

32)町田浩祥,井上純人,佐藤環,五十嵐朗,柴田陽光,久保田功: 症例 眼窩内・上顎洞内病変を伴い,片側性に発症した好酸球性肺炎の1. 日本呼吸器学会誌. 2015; 4(4): 327-331

33)西山悟史,和根崎真大,豊島拓,渡邉哲,久保田功,川崎良,平山敦士,深尾彰,徳永正靭: 山形県急性心筋梗塞発症登録評価研究事業平成25年のまとめ. 山形県医師会会報. 2015; 767: 29-33

34)石野光則,池野栄一郎,鈴木智隆,武村昭宣,北原辰郎,新関武史,山内聡,久保田功: 早期診断・再灌流療法に成功したWellens症候群の3症例. 心臓. 2015; 47(8): 993-999

35)中野寛之,井上純人,佐藤建人,佐藤正道,山内啓子,五十嵐朗,阿部修一,柴田陽光,久保田功: 急性呼吸不全を呈した血管内リンパ腫の2. 日本胸部臨床. 2015; 74(11): 1281-1286